These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
251 related items for PubMed ID: 18801351
1. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V. Clin Biochem; 2008 Nov; 41(16-17):1330-4. PubMed ID: 18801351 [Abstract] [Full Text] [Related]
2. Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. Leira R, Rodríguez-Yáñez M, Castellanos M, Blanco M, Nombela F, Sobrino T, Lizasoain I, Dávalos A, Castillo J. J Intern Med; 2006 Oct; 260(4):343-9. PubMed ID: 16961671 [Abstract] [Full Text] [Related]
3. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Rodríguez-Yáñez M, Castellanos M, Blanco M, García MM, Nombela F, Serena J, Leira R, Lizasoain I, Dávalos A, Castillo J. Neurology; 2006 Dec 12; 67(11):1973-8. PubMed ID: 17159103 [Abstract] [Full Text] [Related]
4. Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D'Aguanno G, La Placa S, Pecoraro R, Arnao V, Marino L, Monaco S, Natalè E, Licata G, Pinto A. J Neuroimmunol; 2009 Oct 30; 215(1-2):84-9. PubMed ID: 19695716 [Abstract] [Full Text] [Related]
5. Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke. Alvarez-Sabín J, Penalba A, Quintana M, Krupinski J, García-Bonilla L, Montaner J. Cerebrovasc Dis; 2009 Oct 30; 28(4):371-7. PubMed ID: 19641312 [Abstract] [Full Text] [Related]
6. Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke. Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A. Thromb Haemost; 2009 May 30; 101(5):929-37. PubMed ID: 19404547 [Abstract] [Full Text] [Related]
7. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Welsh P, Barber M, Langhorne P, Rumley A, Lowe GD, Stott DJ. Cerebrovasc Dis; 2009 May 30; 27(3):247-53. PubMed ID: 19176958 [Abstract] [Full Text] [Related]
8. Blood pressure and antihypertensive therapy as predictors of early outcome in acute ischemic stroke. Keezer MR, Yu AY, Zhu B, Wolfson C, Côté R. Cerebrovasc Dis; 2008 May 30; 25(3):202-8. PubMed ID: 18212508 [Abstract] [Full Text] [Related]
9. Primary end-point times, functional outcome and adverse event profile after acute ischaemic stroke. Ali M, Sacco RL, Lees KR, VISTA investigators. Int J Stroke; 2009 Dec 30; 4(6):432-42. PubMed ID: 19930052 [Abstract] [Full Text] [Related]
10. Recovery after ischemic stroke: criteria for good outcome by level of disability at day 7. Hallevi H, Albright KC, Martin-Schild SB, Barreto AD, Morales MM, Bornstein N, Ifejika NL, Shuaib A, Grotta JC, Savitz SI, VISTA investigators. Cerebrovasc Dis; 2009 Dec 30; 28(4):341-8. PubMed ID: 19628935 [Abstract] [Full Text] [Related]
12. The stroke trial - can we predict clinical outcome of patients with ischemic stroke by measuring soluble cell adhesion molecules (CAM)? Blum A, Khazim K, Merei M, Peleg A, Blum N, Vaispapir V. Eur Cytokine Netw; 2006 Dec 30; 17(4):295-8. PubMed ID: 17353165 [Abstract] [Full Text] [Related]
13. Impact of comorbidity on ischemic stroke outcome. Fischer U, Arnold M, Nedeltchev K, Schoenenberger RA, Kappeler L, Höllinger P, Schroth G, Ballinari P, Mattle HP. Acta Neurol Scand; 2006 Feb 30; 113(2):108-13. PubMed ID: 16411971 [Abstract] [Full Text] [Related]
14. Preliminary findings of the effects of autonomic dysfunction on functional outcome after acute ischemic stroke. Xiong L, Leung H, Chen XY, Han JH, Leung T, Soo Y, Wong E, Chan A, Lau A, Wong KS. Clin Neurol Neurosurg; 2012 May 30; 114(4):316-20. PubMed ID: 22088362 [Abstract] [Full Text] [Related]
15. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. Wunderlich MT, Wallesch CW, Goertler M. J Neurol Sci; 2004 Dec 15; 227(1):49-53. PubMed ID: 15546591 [Abstract] [Full Text] [Related]
16. Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Shenhar-Tsarfaty S, Assayag EB, Bova I, Shopin L, Berliner S, Shapira I, Bornstein NM. Thromb Res; 2008 Dec 15; 122(2):167-73. PubMed ID: 18048088 [Abstract] [Full Text] [Related]
17. IL-6: an early marker for outcome in acute ischemic stroke. Waje-Andreassen U, Kråkenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, Vedeler CA. Acta Neurol Scand; 2005 Jun 15; 111(6):360-5. PubMed ID: 15876336 [Abstract] [Full Text] [Related]
18. Relationship between admission serum C-reactive protein and short term outcome following acute ischaemic stroke at a tertiary health institution in Nigeria. Abubakar SA, Okubadejo NU, Ojo OO, Oladipo O, Ojini FI, Danesi MA. Niger J Clin Pract; 2013 Jun 15; 16(3):320-4. PubMed ID: 23771453 [Abstract] [Full Text] [Related]
19. Probable role of immunological tolerance to ischemia injury in brain. Beridze M, Shakarishvili R, Gogokhia N. Georgian Med News; 2008 Oct 15; (163):30-5. PubMed ID: 18997250 [Abstract] [Full Text] [Related]
20. Link between interleukin-10 level and outcome after ischemic stroke. Chang LT, Yuen CM, Liou CW, Lu CH, Chang WN, Youssef AA, Yip HK. Neuroimmunomodulation; 2010 Oct 15; 17(4):223-8. PubMed ID: 20203528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]